Advertisement
Research Article

A Pathogen Type III Effector with a Novel E3 Ubiquitin Ligase Architecture

  • Alexander U. Singer equal contributor,

    equal contributor Contributed equally to this work with: Alexander U. Singer, Sebastian Schulze

    Affiliations: Banting and Best Department for Medical Research, University of Toronto, C.H. Best Institute, Toronto, Ontario, Canada, Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada

    X
  • Sebastian Schulze equal contributor,

    equal contributor Contributed equally to this work with: Alexander U. Singer, Sebastian Schulze

    Affiliation: Department of Genetics, Martin Luther University Halle-Wittenberg, Halle, Germany

    X
  • Tatiana Skarina,

    Affiliations: Banting and Best Department for Medical Research, University of Toronto, C.H. Best Institute, Toronto, Ontario, Canada, Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada

    X
  • Xiaohui Xu,

    Affiliations: Banting and Best Department for Medical Research, University of Toronto, C.H. Best Institute, Toronto, Ontario, Canada, Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada

    X
  • Hong Cui,

    Affiliations: Banting and Best Department for Medical Research, University of Toronto, C.H. Best Institute, Toronto, Ontario, Canada, Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada

    X
  • Lennart Eschen-Lippold,

    Affiliation: Leibniz Institute of Plant Biochemistry, Halle, Germany

    X
  • Monique Egler,

    Affiliation: Department of Genetics, Martin Luther University Halle-Wittenberg, Halle, Germany

    Current address: Scil Proteins GmbH, Halle, Germany.

    X
  • Tharan Srikumar,

    Affiliation: Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto, MaRS TMDT 9-805, Toronto, Ontario, Canada

    X
  • Brian Raught,

    Affiliation: Ontario Cancer Institute and Department of Medical Biophysics, University of Toronto, MaRS TMDT 9-805, Toronto, Ontario, Canada

    X
  • Justin Lee,

    Affiliation: Leibniz Institute of Plant Biochemistry, Halle, Germany

    X
  • Dierk Scheel,

    Affiliation: Leibniz Institute of Plant Biochemistry, Halle, Germany

    X
  • Alexei Savchenko mail,

    alexei.savchenko@utoronto.ca (AS); ulla.bonas@genetik.uni-halle.de (UB)

    Affiliations: Banting and Best Department for Medical Research, University of Toronto, C.H. Best Institute, Toronto, Ontario, Canada, Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, Canada

    X
  • Ulla Bonas mail

    alexei.savchenko@utoronto.ca (AS); ulla.bonas@genetik.uni-halle.de (UB)

    Affiliation: Department of Genetics, Martin Luther University Halle-Wittenberg, Halle, Germany

    X
  • Published: January 24, 2013
  • DOI: 10.1371/journal.ppat.1003121

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Correction: A Pathogen Type III Effector with a Novel E3 Ubiquitin Ligase Architecture

Alexander U. Singer, Sebastian Schulze, Tatiana Skarina, Xiaohui Xu, Hong Cui, Lennart Eschen-Lippold, Monique Egler, Tharan Srikumar, Brian Raught, Justin Lee, Dierk Scheel, ...
Correction | published 7 May 2013 | PLOS Pathogens
doi:10.1371/annotation/8c6eaae4-72a7-460a-8b1a-f855731f3706